Facioscapulohumeral Muscular Dystrophy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy (FSHD) is a progressive genetic disorder characterized by muscle weakness, primarily affecting the face, shoulders, and upper arms. While there's no cure, effective management and treatment can significantly improve quality of life. TheDrugClub is dedicated to helping individuals and families afford the necessary medications to manage conditions like FSHD, making vital treatments more accessible.
What is Facioscapulohumeral Muscular Dystrophy (FSHD)?
Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic, progressive muscle disorder that causes weakness and wasting of muscles. It's one of the most common forms of muscular dystrophy, affecting approximately one in 8,000 to 15,000 people. The condition typically begins in the face (facio), shoulders (scapulo), and upper arms (humeral), often in adolescence or early adulthood, but can manifest at any age. Symptoms can vary widely, from mild to severe, and may include difficulty smiling, lifting arms, foot drop, and problems with walking. Over time, the weakness can spread to other parts of the body, including the trunk and lower limbs.
Common Treatments and Medications for FSHD
Currently, there is no cure for FSHD, but treatments focus on managing symptoms, maintaining muscle function, and improving quality of life. Physical therapy and occupational therapy are cornerstones of management, helping patients improve strength, flexibility, and daily living skills. Assistive devices like braces or wheelchairs may become necessary as the disease progresses. Pain management, often involving over-the-counter pain relievers or prescribed medications, is also a crucial aspect of care.
Recently, significant progress has been made in FSHD treatment. Medications such as Rezlidhia (losmapimod) have been approved, offering the first and only treatment specifically indicated to slow disease progression in adults with FSHD. This medication works by targeting specific pathways involved in muscle damage. As these new, often high-cost, treatments become available, finding ways to afford them is more important than ever.
How TheDrugClub Members Save on Prescriptions
Managing a chronic condition like FSHD often involves ongoing medication costs. TheDrugClub offers a straightforward solution to help you save on your prescriptions, including those for FSHD. For a low monthly membership fee – just $
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.